DOTASYNTHESE

Patent europeic · EP3390373 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP3390373
Numer da la dumonda
EP16816670
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
19-12-2016
Publitgà
24-10-2018
Concedì
13-12-2023
Stritgà
23-07-2024
Motiv
Taxa annuala betg pajada
Classas IPC
C07D 257/02 (2006.01)
Prioritad
GB 201522412 18.12.2015
Dumonda PCT
PCT/EP2016/081705 19.12.2016
Publicaziun PCT
WO2017/103258 22.06.2017
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 23-10-2024

    Midada

    Published in Swissreg on 23.10.2024

  2. 23-07-2024

    Stritgà, taxa betg pajada

    Published in Swissreg on 23.07.2024

  3. 13-12-2023

    Concedì

    Published in Swissreg on 13.12.2023

Partidas

Possessur

GE Healthcare AS

Nycoveien 1-2 P.O. Box 4220 Nydalen, 0401 Oslo, NO

Inventur

GAUSEMEL, Ingvil

N-0401 Oslo, NO

THANING, Mikkel, Jacob

N-0401 Oslo, NO

AABYE, Arne, Wang

N-0401 Oslo, NO

HUSSAIN, Khalid

1064 Oslo, NO

ENES, Nikolai

N-0401 Oslo, NO

SUMIHAR, Silalahi

Lindesnes 4521, NO

MEIJER, Andreas, Richard

N-0401 Oslo, NO

NILSEN, Sondre

N-0401 Oslo, NO

HAUGAN, Jarle, Andre

N-0401 Oslo, NO

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.